This week’s top performers have been trying to find profits amid a market downturn. Of course, all three major averages will end the week lower, which will be the third negative week in a row. Among the highlights of the week, there are two names that Wall Street believes has plenty of room to run. DXC Technology, was up 9.7% in the week to the end of Thursday. Shares are up 32.4% above the average analyst price target. Bath & Body Works, which was up more than 4% for the week, was up 31.4%, according to FactSet. Here are the companies that performed better this week and analysts’ positions on the stock. To find these names, CNBC Pro scoured the stocks in the space with the best performer of the week to date. While DXC Technology and Bath & Body Works stand out as the names with the biggest upside potential, several others have double-digit profits, according to analysts’ average price targets. Abbott Laboratories posted an 18.6% gain, with 56.5% of analysts rating the stock a buy. The healthcare company was up nearly 3% this week through Thursday. Ulta Beauty, which reported better-than-expected results for its latest quarter last week, is up just over 3% this week through Thursday. Raymond James named this retailer one of the top consumer choices. UBS also highlighted Ulta as one of the highly persuasive stocks that could outperform regardless of the decline. According to the average analyst price target, Ulta stock is up 14.6%. Meanwhile, shares of Dollar General are up 2.7% this week through Thursday and add another 10.5%, according to analysts’ average price target. Last week, the discount retailer enhanced its same-store sales guidance for the fiscal year. It currently exceeds Wall Street expectations.